MedPath Search

Found 538913 clinical trials

Sort by:

Transversus Thoracic Muscle Plane Block, Erector Spinae Plane Block and Paravertebral Block for Analgesia in Video-Assisted Thoracic Surgery

Not Applicable

Not yet recruiting

Conditions: Transversus Thoracic Muscle Plane Block
Erector Spinae Plane Block
Paravertebral Block
Analgesia
Video-Assisted Thoracic Surgery

First Posted Date: 2025-05-23

Last Posted Date: 2025-05-23

Lead Sponsor: Tanta University

Target Recruit Count: 60

Registration Number: NCT06987136

Locations: 🇪🇬
Tanta University, Tanta, El-Gharbia, Egypt

Lactobacillus Plantarum and Hormonal Regulation in Obese Women

Not Applicable

Recruiting

Conditions: Obesity, Women

First Posted Date: 2025-05-23

Last Posted Date: 2025-05-23

Lead Sponsor: Wecare Probiotics Co., Ltd.

Target Recruit Count: 100

Registration Number: NCT06987279

Locations: 🇨🇳
Fuwai Central-China Cardiovascular Hospital, Zhengzhou, Henan, China

Bryophyllum Pinnatum Tea as a Novel Treatment for Recurrent Kidney Stone Formers

Early Phase 1

Conditions: Kidney Calculi
Calcium Oxalate Kidney Stones
Calcium Phosphate Kidney Stones

First Posted Date: 2025-05-23

Last Posted Date: 2025-05-23

Lead Sponsor: Indra Gupta

Target Recruit Count: 25

Registration Number: NCT06987084

Locations: 🇨🇦
McGill University Health Centre (Glen Site), Montreal, Quebec, Canada

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight

Phase 2

Recruiting

Conditions: Alcohol Use Disorder (AUD)

Interventions: Drug: Pemvidutide

First Posted Date: 2025-05-23

Last Posted Date: 2025-05-23

Lead Sponsor: Altimmune, Inc.

Target Recruit Count: 100

Registration Number: NCT06987513

Locations: 🇺🇸
Altimmune Clinical Study Site, Richmond, Virginia, United States

Evaluation of Decision Compatibility Between a Multidisciplinary Cancer Board and ChatGPT-4O

Completed

Conditions: Cancer
Artificial Intelligence

First Posted Date: 2025-05-23

Last Posted Date: 2025-05-23

Lead Sponsor: Sebahattin Celik MD

Target Recruit Count: 100

Registration Number: NCT06986564

Locations: 🇹🇷
Van state hospital, general surgery department, Van, Turkey

REGEND001 Autologous Basal Layer Stem Cell Transplantation for Bronchiectasis: A Translational Application Study

Phase 1

Not yet recruiting

Conditions: Bronchiectasis Adult

Interventions: Biological: REGEND001 Autologous Basal Layer Stem Cell Suspension

First Posted Date: 2025-05-23

Last Posted Date: 2025-05-23

Lead Sponsor: Ruijin Hospital

Target Recruit Count: 10

Registration Number: NCT06987214

The Effect of an Augmented Reality Game on Pain, Fear, and Care Satisfaction Levels During Allergy Testing in Children Aged 4-12 Years

Not Applicable

Completed

Conditions: Augmented Reality

First Posted Date: 2025-05-23

Last Posted Date: 2025-05-23

Lead Sponsor: Koç University

Target Recruit Count: 66

Registration Number: NCT06986655

Locations: 🇹🇷
Koç University Hospital, Istanbul, Zeytinburnu, Turkey

Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy

Not Applicable

Not yet recruiting

Conditions: Lung Cancer (NSCLC)
Geriatric Assessment
Stereotactic Body Radiation Therapy (SBRT)

First Posted Date: 2025-05-23

Last Posted Date: 2025-05-23

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 64

Registration Number: NCT06987890

Glucagon Dose-Response in Patients With Post-Bariatric Hypoglycemia

Not Applicable

Recruiting

Conditions: Hypoglycemia
Hypoglycemia, Reactive
Bariatric Surgery

Interventions: Drug: Glucagon for Injection (Fresenius Kabi USA)

First Posted Date: 2025-05-23

Last Posted Date: 2025-05-23

Lead Sponsor: Joslin Diabetes Center

Target Recruit Count: 28

Registration Number: NCT06986603

Locations: 🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸
Joslin Diabetes Center, Boston, Massachusetts, United States

TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial

Phase 2

Not yet recruiting

Conditions: Nasopharyngeal Carcinoma (NPC)

Interventions: Drug: Toripalimab
Drug: Capecitabine
Procedure: salvage surgery

First Posted Date: 2025-05-23

Last Posted Date: 2025-05-23

Lead Sponsor: Sun Yat-sen University

Target Recruit Count: 62

Registration Number: NCT06987123